Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Combination Therapy with Intravitreal Aflibercept and Verteporfin Photodynamic Therapy in Patients with Polypoidal Choroidal Vasculopathy: A Prospective Case-series Study

Trial Profile

Effect of Combination Therapy with Intravitreal Aflibercept and Verteporfin Photodynamic Therapy in Patients with Polypoidal Choroidal Vasculopathy: A Prospective Case-series Study

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Aflibercept (Primary) ; Verteporfin (Primary)
  • Indications Polypoidal choroidal vasculopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top